White label – Pompe disease - ClinicalTrials.eu

Study on Replacing CNIs with Belatacept for Kidney Transplant Patients with Early Graft Dysfunction 3 to 12 Months Post-Transplant

Not recruiting

2 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Belatacept
Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Not recruiting

3 1 1
Investigated Diseases:
- Lung disorder
Investigated Drugs:
- Baricitinib
+8
Study on Calcium Chloride Hexahydrate, Irreversible Electroporation, and Pembrolizumab for Patients with Metastatic Colorectal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Colorectal cancer stage IV
Investigated Drugs:
- Calcium Chloride Hexahydrate
- Pembrolizumab
Study of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
+2
Long-term Safety Study of Miransertib for Patients with PIK3CA-related Overgrowth Spectrum or Proteus Syndrome

Not recruiting

2 1 1
Investigated Diseases:
- Proteus syndrome
- PIK3CA related overgrowth spectrum
Investigated Drugs:
- Miransertib
Study on Tacrolimus Dosing for Stable Adult Kidney Transplant Patients in the First Year After Transplantation

Not recruiting

2 1 1 1
Investigated Drugs:
- Tacrolimus
Study on Epinephrine and Amiodarone for Patients with Cardiac Arrest Outside the Hospital

Not recruiting

2 1 1 1
Investigated Diseases:
- Cardiac arrest
Investigated Drugs:
- Adrenaline Tartrate Ph. Eur.
Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Not recruiting

2 1
Investigated Diseases:
- Lung disorder
Investigated Drugs:
- Bemcentinib
+4
Study on Heart Health in Type 2 Diabetes Patients Using Semaglutide and Dapagliflozin Combination

Not recruiting

3 1 1 1
Investigated Diseases:
- Type 2 diabetes mellitus
Investigated Drugs:
Study on Tofacitinib for Patients with Mycosis Fungoides

Not recruiting

2 1 1 1
Investigated Drugs:
- Tofacitinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies